Literature DB >> 10644064

Some important considerations in the use of cyclodextrins.

J Blanchard1, S Proniuk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10644064     DOI： 10.1023/a:1011930821801

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  6 in total

1.  Thermodynamics of binding of neutral molecules to sulfobutyl ether beta-cyclodextrins (SBE-beta-CDs): the effect of total degree of substitution.

Authors:  V Zia; R A Rajewski; V J Stella
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

Review 2.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

3.  Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.

Authors:  Akshay Muralidhar; Ivan A Borbon; Dyadin M Esharif; Wangjing Ke; Rinu Manacheril; Michael Daines; Robert P Erickson
Journal:  Mol Genet Metab       Date:  2011-03-05       Impact factor: 4.797

Review 4.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

5.  Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins.

Authors:  E A Zannou; W H Streng; V J Stella
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

6.  Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrate.

Authors:  Arpansiree Wongmekiat; Yuichi Tozuka; Toshio Oguchi; Keiji Yamamoto
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.